Elanco Animal Health Incorporated announced that it has appointed two new independent directors, Kathy Turner and Craig Wallace, to its Board of Directors, effective immediately, expanding the Board to 14 members.
Ms. Turner brings significant global experience in both the animal health and broader healthcare industries. She has held senior leadership positions at IDEXX Laboratories, including most recently as Chief Marketing Officer, and served in various roles of increasing responsibility at Abbott Laboratories. Mr. Wallace is a well-respected animal health leader with more than 30 years of executive experience at companies such as Fort Dodge Animal Health, Trupanion and Ceva. Ms. Turner and Mr. Wallace also joined the Board's Finance, Strategy and Oversight Committee, which has been renamed to better reflect its charter and mandate.